Turnstone Biologics Corp. – Plans of Reorganization, Merger, Acquisition or Similar – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 25 pages Contingent Value Rights Agreement

from 8-K/A 105 pages Agreement and Plan of Merger Among Xoma Royalty Corporation Xra 3 Corp. and Turnstone Biologics Corp. Dated as of June 26, 2025

from 8-K 32 pages Asset Purchase Agreement

from 8-K 74 pages Agreement and Plan of Merger Among Xoma Royalty Corporation Xra 3 Corp. and Turnstone Biologics Corp. Dated as of June 26, 2025

from S-1 91 pages Agreement and Plan of Merger and Reorganization Dated as of December 11, 2020 by and Among Turnstone Biologics Corp., Flatiron Merger Sub I, Inc., Flatiron Merger Sub II, LLC, Myst Therapeutics, Inc., and Timothy Langer, Solely in His Capacity as Equityholders Representative

from DRS 91 pages Agreement and Plan of Merger and Reorganization Dated as of December 11, 2020 by and Among Turnstone Biologics Corp., Flatiron Merger Sub I, Inc., Flatiron Merger Sub II, LLC, Myst Therapeutics, Inc., and Timothy Langer, Solely in His Capacity as Equityholders Representative